By REUTERS
NYT Business
Novartis AG Chief Executive Vas Narasimhan said his company's prescription drug prices have been "flat to negative" over the last three years, and directed blame for high costs for U.S. patients on industry middlemen that manage drug benefits.
Published date: February 7, 2019 at 12:46AM
Reuters
New York Times article
No comments:
Post a Comment